口服葡萄糖耐量试验中异亮氨酸、肌氨酸和二甲基甘氨酸的变化作为糖尿病风险因素
研究结合口服葡萄糖耐量试验(OGTT)与代谢组学,比较正常糖耐量(NGT)、糖调节受损(IGR)和新诊断2型糖尿病(NDM)人群的代谢物变化。结果显示OGTT中异亮氨酸、肌氨酸和乙酸水平与NDM风险相关,异亮氨酸和乙酸与IGR风险相关,提示这些代谢物变化是糖尿病发展的潜在风险因素。
要点
- OGTT中异亮氨酸水平在NGT与NDM组间及NGT与IGR组间存在差异。
- OGTT中异亮氨酸、肌氨酸和乙酸水平与NDM风险相关。
- OGTT中异亮氨酸和乙酸水平与IGR风险相关。
核心结论
- 不同糖耐量状态个体在葡萄糖诱导后代谢谱不同,OGTT中代谢物水平变化是糖尿病发展的潜在风险因素。
研究设计与样本
- 研究将参与者分为正常糖耐量(NGT)、糖调节受损(IGR)和新诊断2型糖尿病(NDM)组,在OGTT的0、30、60、120和180分钟采集血清,评估代谢物水平变化并比较三组代谢谱。
- 采用广义估计方程(GEE)分析OGTT中代谢物水平与糖尿病及糖尿病前期风险的关系,回归结果校正了性别、体重指数、空腹胰岛素水平、心率、吸烟状态和血压。
主要发现
- 葡萄糖摄入改变了代谢谱,诱导糖酵解中间产物增加,氨基酸、甘油、酮体和甘油三酯减少。
- 异亮氨酸水平在NGT与NDM组间及NGT与IGR组间存在差异。
- 糖尿病组OGTT中肌氨酸水平的变化与甘氨酸水平的变化方向相反。
- GEE分析显示,OGTT中异亮氨酸、肌氨酸和乙酸水平与NDM风险相关,异亮氨酸和乙酸水平与IGR风险相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Current metabolomics studies in diabetes have focused on the fasting state, while only a few have addressed the satiated state. OBJECTIVE: We combined the oral glucose tolerance test (OGTT) and metabolomics to examine metabolite-level changes in populations with different glucose tolerance statuses and to evaluate the potential risk of these changes for diabetes. METHODS: We grouped participants into those with normal glucose tolerance (NGT), impaired glucose regulation (IGR), and newly diagnosed type 2 diabetes (NDM). During the OGTT, serum was collected at 0, 30, 60, 120, and 180 minutes. We evaluated the changes in metabolite levels during the OGTT and compared metabolic profiles among the 3 groups. The relationship between metabolite levels during the OGTT and risk of diabetes and prediabetes was analyzed using a generalized estimating equation (GEE). The regression results were adjusted for sex, body mass index, fasting insulin levels, heart rate, smoking status, and blood pressure. RESULTS: Glucose intake altered metabolic profile and induced an increase in glycolytic intermediates and a decrease in amino acids, glycerol, ketone bodies, and triglycerides. Isoleucine levels differed between the NGT and NDM groups and between the NGT and IGR groups. Changes in sarcosine levels during the OGTT in the diabetes groups were opposite to those in glycine levels. GEE analysis revealed that during OGTT, isoleucine, sarcosine, and acetic acid levels were associated with NDM risks, and isoleucine and acetate levels with IGR risks. CONCLUSION: Metabolic profiles differ after glucose induction in individuals with different glucose tolerance statuses. Changes in metabolite levels during OGTT are potential risk factors for diabetes development.
引用
- Liu Y, Liu X, He Q, et al. Changes in Isoleucine, Sarcosine, and Dimethylglycine During OGTT as Risk Factors for Diabetes. J Clin Endocrinol Metab. 2024. PMID: 38214112. doi:10.1210/clinem/dgae018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。